Do food warning labels actually work? Answering your questions.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
Becker's Hospital Review20h
FDA warns GLP-1 compounder over safety rules
The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...
Hosted on MSN17h
Lay's potato chips recalled over life-threatening risk as FDA issues warning
Lay recall on Lay's Classic Potato Chips across Oregon and Washington was updated to a Class 1 recall by the FDA on Thursday.
FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’
The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing ...
The American Journal of Managed Care11h
Suzetrigine: First-in-Class Non-Opiate Pain Therapy is Approved by FDA
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
The American Journal of Managed Care23h
FDA-Approved IV Iron Formulations
Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and ...
FDA approves Vertex's first-in-class non-opioid analgesic for acute pain
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...
Health on MSN22h
Lay’s Potato Chips Recall: FDA Sets Highest Risk Level for Over 6,000 Bags
The FDA just set the highest risk level—class 1—for the recall of Lay's Classic Potato Chips amid concern that they contain ...
Healio15h
Study: Montelukast not associated with neuropsychiatric events in children
Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.
CNET on MSN20h
Red Dye No. 3 Can Be Found in These 9 Foods in Your Pantry
After the Red No. 3 ban, there are now eight color additives approved by the FDA. They are FD&C Blue No. 1, FD&C Blue No. 2, ...
Lab-grown meat rebrands itself to woo Trump — and RFK Jr
But the poultry that went into these dishes hadn't come from a farm — it was grown from animal cells in a lab. Local ...